Patents by Inventor Jonathan Boutell

Jonathan Boutell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240117424
    Abstract: Reusable flow cells for sequencing which exhibit signal intensity retention over numerous use cycles, the active surface of which contains poly-azide functional moieties, methods of treating flow cells surfaces with reagents to provide such poly-azide functional moieties, and reagents therefor.
    Type: Application
    Filed: September 12, 2023
    Publication date: April 11, 2024
    Applicant: Illumina, Inc.
    Inventors: Jonathan Boutell, Wayne George, Xiaolin Wu
  • Publication number: 20240102067
    Abstract: This disclosure relates to novel mjresynthesis kits and methods, in particular for use in pairwise sequencing.
    Type: Application
    Filed: September 25, 2023
    Publication date: March 28, 2024
    Applicant: Illumina, Inc.
    Inventors: Kay Klausing, Jonathan Boutell, Trina Osothprarop, Oliver Miller, Justin Robbins
  • Publication number: 20230348973
    Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing. In some examples, a solid support is used for template capture and amplification.
    Type: Application
    Filed: March 30, 2023
    Publication date: November 2, 2023
    Applicant: ILLUMINA CAMBRIDGE LIMITED
    Inventors: Xiaoyu Ma, Mathieu Lessard-Viger, Eric Brustad, Jeffrey Fisher, Jonathan Boutell, Weihua Chang
  • Patent number: 11661627
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: May 30, 2023
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Publication number: 20220333178
    Abstract: A method for seeding and amplifying target nucleic acids derived from a sample in a cluster at a site on a surface of a substrate includes retaining at least a portion of the target nucleic acids in an inactive form that cannot seed to provide a relatively low concentration of active form target nucleic acids available for seeding. As the active form target nucleic acids seed on the surface of the substrate, they may be amplified. Because the concentration of active form target nucleic acids is low, the likelihood is low that a second active form target nucleic acid will seed at the same site within the same cluster before the first active form target nucleic acid is sufficiently amplified to dominate. Accordingly, the likelihood that the cluster will pass filters is increased relative to traditional seeding and amplification methods employing a higher concentration of active form target nucleic acids.
    Type: Application
    Filed: March 21, 2022
    Publication date: October 20, 2022
    Inventors: Gary Mark Skinner, Geraint Evans, Niall Gormley, Jonathan Boutell, Matthew W. Kellinger, Michael Previte, Molly He
  • Publication number: 20210010071
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 14, 2021
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Patent number: 10808277
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: October 20, 2020
    Assignees: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Publication number: 20180187252
    Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.
    Type: Application
    Filed: December 15, 2017
    Publication date: July 5, 2018
    Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
  • Publication number: 20150050657
    Abstract: Provided herein is a method of selecting target nucleic acids on a support. The method includes providing a plurality of beads each bead comprising one or more oligonucleotides, providing a support with a plurality of primers with a sequence complementary to at least a portion of the oligonucleotides on the beads, contacting the beads with the support wherein the oligonucleotides on the beads bind to the primers on the support, performing an extension reaction by extending the primers on the support to produce capture oligonucleotides, contacting the support comprising the capture oligonucleotides with the target nucleic acids, and extending the capture oligonucleotides bound to target nucleic acids to produce target extension products comprising a sequence complementary to at least a portion of the target nucleic acids. Optionally, the method further includes amplifying the target extension products.
    Type: Application
    Filed: May 28, 2013
    Publication date: February 19, 2015
    Applicant: Illumina Cambridge Limited
    Inventors: Roberto Rigatti, Jonathan Boutell
  • Publication number: 20080009420
    Abstract: The present invention is directed to a method for isothermal amplification of a plurality of different target nucleic acids, wherein the different target nucleic acids are amplified using universal primers and colonies produced thereby can be distinguished from each other. The method, therefore, generates distinct colonies of amplified nucleic acid sequences that can be analyzed by various means to yield information particular to each distinct colony.
    Type: Application
    Filed: March 19, 2007
    Publication date: January 10, 2008
    Inventors: Gary Schroth, David Lloyd, Lu Zhang, Tobias Barrost, Roberto Rigatti, Jonathan Boutell